Apollo Hospitals Intrinsic Value
Apollo Hospitals intrinsic value. Apollo Hospitals (APOLLOHOSP) median intrinsic value is ₹2281.35 from 10 valuation models (range ₹1521–₹5175), vs current price ₹7604.50 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit APOLLOHOSP screener.
APOLLOHOSP Valuation Methods Summary — DCF, Graham Number & P/E
Apollo Hospitals intrinsic value across 10 models vs current price ₹7604.50 — upside/downside and value range per method. Compare with Apollo Hospitals value estimation to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2281.35 | ₹1825.08 - ₹2737.62 | -70.0% | EPS: ₹147.28, Sector P/E: 12x |
| Book Value Method | asset | ₹1520.90 | ₹1368.81 - ₹1672.99 | -80.0% | Book Value/Share: ₹1385.42, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹2960.00 | ₹2664.00 - ₹3256.00 | -61.1% | Revenue/Share: ₹3700.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹3550.00 | ₹3195.00 - ₹3905.00 | -53.3% | EBITDA: ₹4260.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹5175.12 | ₹4140.10 - ₹6210.14 | -31.9% | CF Growth: 13.9%, Discount: 15% |
| PEG Ratio Method | growth | ₹2281.35 | ₹2053.22 - ₹2509.49 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹2281.35 | ₹2053.22 - ₹2509.49 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹4897.78 | ₹4408.00 - ₹5387.56 | -35.6% | ROE: 22.1%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹2281.35 | ₹2053.22 - ₹2509.49 | -70.0% | EPS: ₹147.28, BVPS: ₹1385.42 |
| Dividend Yield Method | dividend | ₹2281.35 | ₹2053.22 - ₹2509.49 | -70.0% | DPS: ₹20.00, Target Yield: 3.5% |
APOLLOHOSP Intrinsic Value vs Market Price — All Valuation Models
Apollo Hospitals fair value range ₹1521–₹5175 vs current market price ₹7604.50 across 10 valuation models. Read APOLLOHOSP dividend history for the complete payout history and dividend yield track record.
APOLLOHOSP Intrinsic Value Analysis — Undervalued or Overvalued?
Apollo Hospitals median intrinsic value ₹2281.35, current price ₹7604.50 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of APOLLOHOSP?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Apollo Hospitals (APOLLOHOSP) is ₹2281.35 (median value). With the current market price of ₹7604.50, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹1520.90 to ₹5175.12, indicating ₹1520.90 - ₹5175.12.
Is APOLLOHOSP undervalued or overvalued?
Based on our multi-method analysis, Apollo Hospitals (APOLLOHOSP) appears to be trading above calculated value by approximately 70.0%.
APOLLOHOSP Financial Health — Key Ratios vs Industry Benchmarks
Apollo Hospitals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 22.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 15.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.20x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
APOLLOHOSP Cash Flow Quality — Operating & Free Cash Flow
Apollo Hospitals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹2,856 Cr | ₹1,784 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹2,136 Cr | ₹445 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹1,920 Cr | ₹1,152 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹1,377 Cr | ₹949 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1,696 Cr | ₹1,323 Cr | Positive Free Cash Flow | 8/10 |